Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
Personalized medicine: Signature-guided cancer therapy Personalized cancer therapy is one of the holy grails of oncology, as the ability to determine what treatment would best benefit a patient would serve not only to improve outcomes, but also mitigate side effects from less effective treatments. H...
Enregistré dans:
Auteurs principaux: | Daniel J. McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, Qingxin Liu, Wei Mo, Hui Dai, Yiling Lu, Qinghua Yu, Zhenlin Ju, Jun Yin, Christopher P. Vellano, Bryan Hennessy, Gordon B. Mills, Shiaw-Yih Lin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b2d7262023a5464f9e1788ca4d9c8cbf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
par: Daniel J. McGrail, et autres
Publié: (2018) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
par: Hyoung Kim, et autres
Publié: (2020) -
Data-Driven Anomaly Detection in High-Voltage Transformer Bushings with LSTM Auto-Encoder
par: Imene Mitiche, et autres
Publié: (2021) -
Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
par: Hao Zuo, et autres
Publié: (2020) -
Serine-linked PARP1 auto-modification controls PARP inhibitor response
par: Evgeniia Prokhorova, et autres
Publié: (2021)